DUSP4 and Alzheimer disease: DUSP4 and the select neuroinflammatory, IFNγ, and ERK pathways regulated in female 5xFAD by its overexpression, that we have identified here, may therefore represent gender-specific, pharmacotherapeutic AD targets.